세계의 지속적신대체요법(CRRT) 기기 시장 규모는 2023년에 12억 5,000만 달러에 달했습니다. 이 시장은 2024-2030년의 예측 기간 중 7.39%의 CAGR로 확대하며, 2030년에는 19억 2,000만 달러에 달할 것으로 예측되고 있습니다. CRRT 기기의 수요는 전 세계에서 급성 신부전 및 급성 신장 손상(AKI)의 유병률 증가, 패혈증 발생률 증가, 급성 신장 손상(AKI)을 앓고 있는 ICU 환자들의 부담 증가 AKI를 앓고 있는 중환자실 환자의 부담 증가, 그리고 제품 라인의 기술 발전이 주요 원인으로 꼽힙니다. 간헐적 혈액 정화 시스템에 비해 CRRT의 임상적 우위도 CRRT 기기 시장을 촉진하는 주요 요인입니다.
급성 신장 손상(AKI)은 모든 입원 환자에게 가장 흔한 심각한 합병증 중 하나이며, 입원 환자, 특히 중환자 실 환자에서 발생률이 증가하고 있습니다. 또한 기저질환인 만성신장질환이 AKI의 위험요인으로 인식되고 있습니다. 또한 LANCET 2020에 게재된 연구에 따르면 2017년 모든 단계의 만성콩팥병 환자 6억 9,750만 건 기록되고, 약 120만 명이 이 질환으로 인해 사망했습니다. 만성콩팥병의 유병률 증가와 그에 따른 사망률 증가는 적절한 시기에 적절한 치료를 받을 수 있었습니다면 감소할 수 있었을 것으로 추정됩니다. 깨끗한 혈액을 체내로 되돌려줌으로써 신장을 지원합니다. 따라서 CRRT 세계 시장 성장에 기여하고 있습니다.
또한 지속적 신대체요법의 등장 이후 고투과성 혈액 여과와 고용량 투과성을 중심으로 한 다양한 기술 발전도 세계 CRRT 시장을 촉진할 것으로 예상됩니다.
현재 제조업체들은 CRRT 시술 중 안전하고 신뢰할 수 있는 성능을 발휘할 수 있는 정밀한 장비를 개발하고 있습니다. 또한 이러한 장비는 사용하기 쉬운 인터페이스를 갖추고 있으며, 쉽게 성능을 발휘할 수 있습니다. 예를 들어 Baxter는 최근 2022년에 차세대 CRRT 플랫폼의 최신 버전인 PrisMax 2를 출시할 예정이라고 발표했습니다. 대체요법(CRRT) 및 기타 장기 지지 요법의 제공을 간소화하는 동시에 중환자실(ICU)의 고유한 수요에 대응할 수 있는 유연성을 제공하도록 설계되었습니다. 이러한 요인들이 세계 CRRT 기기 시장의 성장에 기여하고 있습니다.
세계의 지속적신대체요법 기기(CRRT) 시장에 대해 조사했으며, 시장의 개요와 제품 유형별, 모달리티별, 환자별, 최종사용자별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 제공하고 있습니다.
Continuous Renal Replacement Therapy (CRRT) Machines Market By Product Type (Machines and Consumables), Modality (Slow Continuous Ultrafiltration (SCUF), Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodialysis (CVVHD), and Continuous Venovenous Hemodiafiltration (CVVHDF)), Patient (Adult And Pediatric), End-User (Hospitals, Dialysis Centres, and Others), and Geography is projected to grow at a constant CAGR during the forecast period from 2024-2030 on account of significant technological advancement and rising prevalence of acute renal failure.
Global Continuous Renal Replacement Therapy (CRRT) Machines Market was valued at USD 1.25 billion in 2023, growing at a CAGR of 7.39% during the forecast period from 2024 to 2030, to reach USD 1.92 billion by 2030. The demand for CRRT machines is predominantly attributed to the rise in the prevalence of acute renal failure or Acute Kidney Injury (AKI) across the globe, the growing burden of ICU patients with AKI along with an increase in the incidence of sepsis, significant technological advancements in the product line. The clinical advantage of CRRT over intermittent blood purification systems is also a prominent driving factor for the CRRT machines market.
CRRT Machines Market Dynamics:
Acute kidney injury (AKI) is one of the most common serious complications for all hospital admissions, with its incidence increasing among hospitalized patients, particularly those in the intensive care unit. Moreover, it is recognized that underlying chronic kidney disease is a risk factor for AKI. Also, according to a study published in LANCET 2020, in 2017, 697.5 million cases of all-stage CKD were recorded and around 1.2 million died from the indication. The rising prevalence of chronic kidney disorders and their associated deaths could have been reduced through proper and timely treatment through CRRT machines as these machines provide renal support by slowly removing fluid and uremic toxins and returning clean blood to the body over 24 hours duration in critically ill patients suffering from AKI and are hemodynamically unstable. Thus, contributing to the growth of the Global CRRT market.
Furthermore, various technological advancement which mainly comprises high permeability hemofiltration and high volume permeability since the advent of continuous renal replacement therapy is also expected to boost the global CRRT market.
At present, manufacturers are developing precise devices that are safe and give reliable performance during CRRT procedures. Also, for easy performance, these devices are equipped with a user-friendly interface. For instance, recently, in 2022, Baxter announced the launch of its latest version of the next-generation CRRT platform, PrisMax 2. The PrisMax 2 system features new solutions within the company's TrueVue digital health portfolio and is designed to help simplify the delivery of continuous renal replacement therapy (CRRT) and other organ support therapies while providing hospitals the flexibility to meet the unique demands of the intensive care unit (ICU). Thus, such factors are contributing to the upsurge of the global CRRT machines market.
However, certain factors such as the high procedural cost of CRRT are likely to pose a minor hurdle to the growth of the CRRT market.
CRRT Machines Market Segment Analysis:
CRRT Market By Product Type (Machines and Consumables), Modality (Slow Continuous Ultrafiltration (SCUF), Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodialysis (CVVHD), and Continuous Venovenous Hemodiafiltration (CVVHDF)), Patient (Adult and Pediatric), End-User (Hospitals, Dialysis Centres, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the CRRT market modality segment, Continuous Venovenous Hemofiltration (CVVH) holds the highest market. This is owing to the rising incidence of fluid overloads that are frequently found in patients with acute kidney injuries and in the ICU. However, it is also expected that Continuous Venovenous Hemodiafiltration (CVVHDF) will observe lucrative growth during the forecasted period. This is because the CVVHDF treatment modality results in the complete removal of solutes and fluids from the blood as it combines both the principle of convection and diffusion i.e., hemofiltration and hemodialysis by making use of a highly efficient hemofilter for the removal of solute and fluid. Thereby propelling the segmental growth of the CRRT market.
Moreover, most of CRRT machines are compatible with more than two or three modalities which can further fuel the market. In 2019, Baxter launched PrisMax system the company's platform for continuous renal replacement therapy (CRRT), therapeutic plasma exchange (TPE), and organ support therapies (OST). The system delivers all therapy modalities of CRRT and therapeutic plasma exchange (TPE) without additional equipment. Hence, these factors are responsible for the growth of the CVVH modality systems along with CVVHDF modalities during the forecasted period.
North America is expected to dominate the overall CRRT Machines Market:
Among all the regions, North America is expected to dominate the overall CRRT machines market during the forecast period. This domination is due to the growing demand for advanced technologies in CRRT machines, the increasing cases of CKD and associated AKIs in the region are driving regional growth.
Further, the United States represents the largest market worldwide supported by developed healthcare infrastructure and strong R&D expenditure by the key players. Rising product launch and commercialization agreements among the key manufacturers are also anticipated to boost the CRRT market. For instance, the recent launch of the first and only Pediatric and Neonatal Acute Dialysis Machine (Carpediem(TM) systems) in December 2020 which is intended to provide continuous renal replacement therapy (CRRT) to patients weighing between 2.5 and 10 kilograms in the United States is likely to grow the market in the region.
In addition, the integration of telehealth platforms to improve outcomes and the care experience for CKD patients deciding to treat at home is also expected to fuel the market in the region. For instance, in 2019, DaVita incorporated its connective technologies DaVita Care Connect into its home dialysis program to meet the latest COVID-19 regulations implemented by the government to prevent the transmission of infection.
Europe and Asia-Pacific region have the future potential growth for global CRRT machines. This is due to the increasing incidence and prevalence of AKI and rising government initiatives to increase awareness about the advancements in renal therapy which is likely to surge the market. According to the International Society of Nephrology 2022, every year, there are around 13.3 million cases of AKI and the burden is specifically high in emerging countries where the annual incidence is estimated to be 11.3 million.
Therefore, this situation is giving rise to a critical need for CRRT machines thereby augmenting the CRRT market in this region. Moreover, rapid urbanization, an increase in disposable income in emerging countries such as China, India, and others, and the presence of local manufacturers in the region are also projected to drive the global CRRT market.
CRRT Machines Market Key Players:
Some of the key market players operating in the CRRT machines market include Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, NIKKISO CO., LTD., B. Braun Melsungen AG, Asahi Kasei Corporation, Informed SA, Medtronic, and others.
Recent Developmental Activities in CRRT Machines Market:
In August 2020, Baxter obtained US FDA Emergency Use Authorization for Regiocit Replacement Solution used In CRRT.
In April 2020, Fresenius Medical Care received US FDA Emergency Use Authorization for multiFiltrate PRO System and multiBic/multiPlus Solutions to provide CRRT to treat patients in an acute care environment during the COVID-19 pandemic.
Key Takeaways from the CRRT Market Report Study
Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the CRRT machines market.
Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the Global CRRT machines Market.
Various opportunities available for the other competitor in the CRRT machines Market space.
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for CRRT Machines market growth in the coming future?
Target Audience who can be benefited from CRRT Machines Market Report Study
CRRT machines providers
Research organizations and consulting companies
CRRT machines-related organization, association, forum, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders in CRRT Machines
Various End-users who want to know more about the CRRT machines Market and latest technological developments in the CRRT machines market.
Frequently Asked Questions for CRRT Machines Market
What is CRRT Machine?
CRRT machines are used in blood purification therapy in patients suffering with acute renal failure or acute kidney injuries. The machine pumps and controls the rate of blood flow and includes software to safely monitor therapy delivery. These machines are available in four different modes: Slow Continuous Ultrafiltration (SCUF), Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodialysis (CVVHD), and Continuous Venovenous Hemodiafiltration (CVVHDF.
What are the drivers for the Global CRRT Machines Market?
The major factors fuelling the demand for CRRT machines are the rising prevalence of acute renal failure, the growing burden of acute kidney injuries among ICU patients, new product approvals, and the shifting focus of key players for developing advanced products.
What is the market for Global CRRT Machines?
Global Continuous Renal Replacement Therapy (CRRT) Machines Market was valued at USD 1.25 billion in 2023, growing at a CAGR of 7.39% during the forecast period from 2024 to 2030, to reach USD 1.92 billion by 2030.
What are the key players operating in the global CRRT Machines Market?
Some of the key market players operating in the CRRT machines market include Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, NIKKISO CO., LTD., B. Braun Melsungen AG, Asahi Kasei Corporation, Informed SA, Medtronic, and others.
What regions have the highest share in the CRRT Machines market?
North America is expected to dominate the overall CRRT Machines market during the forecast period, 2024 to 2030 due to the advanced healthcare system, increasing prevalence of chronic kidney disorders in the region, and rising product developmental activities among the key market players.